KRAS and posterior cortical atrophy: Previously, the incidence of KRAS was extremely poorly understood among the patients with PCa in Russia, while overall world data reported KRAS pathway mutations for more than 90% cases of metastatic PCa and 65.5% of all the patients with the disease [10, 16].